메뉴 건너뛰기




Volumn 8, Issue 4, 2008, Pages 293-301

Product lifecycle management: Marketing strategies for the pharmaceutical industry

(1)  Kvesic, Dennis Z a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords


EID: 55749104579     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/jmm.2008.23     Document Type: Review
Times cited : (18)

References (23)
  • 1
    • 84990341089 scopus 로고    scopus 로고
    • Defending value and maximizing profitability of innovative pharmaceuticals over their entire life cycles
    • Bruce, L. (2003). Defending value and maximizing profitability of innovative pharmaceuticals over their entire life cycles. Int. J. Med. Market 3, 195-197.
    • (2003) Int. J. Med. Market , vol.3 , pp. 195-197
    • Bruce, L.1
  • 2
    • 24644483477 scopus 로고    scopus 로고
    • Start early, sell more, sell longer
    • Daly, R. & Kolassa, M. (2004). Start early, sell more, sell longer. Pharma. Exec. 1, 8-20.
    • (2004) Pharma. Exec , vol.1 , pp. 8-20
    • Daly, R.1    Kolassa, M.2
  • 3
    • 55749113824 scopus 로고    scopus 로고
    • Strategies for extending the life of patents
    • Spruill, M. W. & Cunningham, M. L. (2005). Strategies for extending the life of patents. BioPharm. Int. 18, 42-45.
    • (2005) BioPharm. Int , vol.18 , pp. 42-45
    • Spruill, M.W.1    Cunningham, M.L.2
  • 4
    • 84986132058 scopus 로고    scopus 로고
    • Surviving patient expiration: Strategies for marketing pharmaceutical products
    • Agrawal, M. & Thakkar, N. (1997). Surviving patient expiration: strategies for marketing pharmaceutical products. J. Product. Brand. Manage. 6, 305-314.
    • (1997) J. Product. Brand. Manage , vol.6 , pp. 305-314
    • Agrawal, M.1    Thakkar, N.2
  • 5
    • 55749113484 scopus 로고    scopus 로고
    • Fact sheet: TRIPS and pharmaceutical patents, (http://www.ppl.nl/ bibliographies/wto/files/6074.pdf). World Trade Organization, accessed 25th November, 2007.
    • Fact sheet: TRIPS and pharmaceutical patents, (http://www.ppl.nl/ bibliographies/wto/files/6074.pdf). World Trade Organization, accessed 25th November, 2007.
  • 7
    • 84990373748 scopus 로고    scopus 로고
    • Pricing policies to handle patent loss or expiry
    • Barak, A. & Wilson, G. (2003). Pricing policies to handle patent loss or expiry. Int. J. Med. Market. 3, 245-249.
    • (2003) Int. J. Med. Market , vol.3 , pp. 245-249
    • Barak, A.1    Wilson, G.2
  • 8
    • 0002815023 scopus 로고
    • Exploit the product life cycle
    • Levitt, T. (1965). Exploit the product life cycle. Harvard Bus. Rev. 43, 81-93.
    • (1965) Harvard Bus. Rev , vol.43 , pp. 81-93
    • Levitt, T.1
  • 9
    • 84992924051 scopus 로고    scopus 로고
    • The art of using secondary patents to improve protection
    • Burdon, M. & Sloper, K. (2003). The art of using secondary patents to improve protection. Int. J. Med. Market. 3, 226-238.
    • (2003) Int. J. Med. Market , vol.3 , pp. 226-238
    • Burdon, M.1    Sloper, K.2
  • 10
    • 24644464917 scopus 로고    scopus 로고
    • Your patent is about to expire: What now?
    • Tuttle, E., Parece, A. & Hector, A. (2004). Your patent is about to expire: What now? Pharma. Exec. 24, 88-98.
    • (2004) Pharma. Exec , vol.24 , pp. 88-98
    • Tuttle, E.1    Parece, A.2    Hector, A.3
  • 11
    • 55749110998 scopus 로고    scopus 로고
    • Generic pharmaceutical association - commercial insights: antihypertensives, (http://www.datamonitor.com/), Datamonitor, accessed 5th September, 2007.
    • Generic pharmaceutical association - commercial insights: antihypertensives, (http://www.datamonitor.com/), Datamonitor, accessed 5th September, 2007.
  • 12
    • 55749104664 scopus 로고    scopus 로고
    • Lifecycle management in the pharmaceutical industry: The unexploited potential, (www.capgemini.com/lifesciences), Capgemini, accessed 3rd February, 2008.
    • Lifecycle management in the pharmaceutical industry: The unexploited potential, (www.capgemini.com/lifesciences), Capgemini, accessed 3rd February, 2008.
  • 14
    • 33846881807 scopus 로고    scopus 로고
    • Innovative marketing strategies after patent expiry: The case of GSK's antibiotic Clamoxyl in France
    • Chandon, P. (2004). Innovative marketing strategies after patent expiry: the case of GSK's antibiotic Clamoxyl in France. Int. J. Med. Market. 4, 65-73.
    • (2004) Int. J. Med. Market , vol.4 , pp. 65-73
    • Chandon, P.1
  • 15
    • 55749089094 scopus 로고
    • The marketing of pharmaceuticals: Standardization or customization?
    • Doherty, G. & Ennew, C. T. (1995). The marketing of pharmaceuticals: standardization or customization? J. Market. Pract. 3, 39-50.
    • (1995) J. Market. Pract , vol.3 , pp. 39-50
    • Doherty, G.1    Ennew, C.T.2
  • 16
    • 33846958019 scopus 로고    scopus 로고
    • The fundamentals of standardizing global marketing strategy
    • Viswanathan, N. K. & Dickson, P. R. (2007). The fundamentals of standardizing global marketing strategy. Int. Market. Rev. 24 46-63.
    • (2007) Int. Market. Rev , vol.24 , pp. 46-63
    • Viswanathan, N.K.1    Dickson, P.R.2
  • 18
    • 34447109035 scopus 로고    scopus 로고
    • Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension
    • Philipp, T., Smith, T. R., Glazer, R., Wernsing, M., Yen, J., Jin, J., Schneider, H. & Pospiech, R. (2007). Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin. Ther. 29, 563-580.
    • (2007) Clin. Ther , vol.29 , pp. 563-580
    • Philipp, T.1    Smith, T.R.2    Glazer, R.3    Wernsing, M.4    Yen, J.5    Jin, J.6    Schneider, H.7    Pospiech, R.8
  • 19
    • 55749113483 scopus 로고    scopus 로고
    • Assessing guidelines strategies and new drugs to get patients to target, (http://www.medscape.com/viewarticle/552438), Brookes, L., accessed 3rd February 2008.
    • Assessing guidelines strategies and new drugs to get patients to target, (http://www.medscape.com/viewarticle/552438), Brookes, L., accessed 3rd February 2008.
  • 20
    • 55749112804 scopus 로고    scopus 로고
    • Hatch, O. & Waxman, H. (1984). Drug price competition and patent term restoration act (Public Law 98-417). United States Federal Law.
    • Hatch, O. & Waxman, H. (1984). Drug price competition and patent term restoration act (Public Law 98-417). United States Federal Law.
  • 21
    • 8844235175 scopus 로고    scopus 로고
    • When form equals substance: The value of form screening in product life-cycle management
    • February
    • Lucas, J. & Burgess, P. (2004). When form equals substance: The value of form screening in product life-cycle management. Pharma Voice February, 54-57.
    • (2004) Pharma Voice , pp. 54-57
    • Lucas, J.1    Burgess, P.2
  • 22
    • 11244346687 scopus 로고    scopus 로고
    • Switching prescription drugs to over-the-counter
    • Cohen, J. P., Paquette, C. & Cairns, C. P. (2005). Switching prescription drugs to over-the-counter. BMJ 330, 39-41.
    • (2005) BMJ , vol.330 , pp. 39-41
    • Cohen, J.P.1    Paquette, C.2    Cairns, C.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.